Terry Chow
Keine laufenden Positionen mehr
Profil
Terry Chow was the founder of Verlyx Pharma, Inc. which was founded in 1999, where he held the title of Scientific Director from 1999 to 2013.
Prior to his founding position, he worked as a Research Officer at the National Research Council of Canada from 1986 to 1989 and as an Assistant Professor at the University of Sherbrooke from 1989 to 1993.
Dr. Chow received his doctorate degree from McGill University in 1981.
Ehemalige bekannte Positionen von Terry Chow
| Unternehmen | Position | Ende |
|---|---|---|
| University of Sherbrooke | Corporate Officer/Principal | 01.01.1993 |
National Research Council of Canada
 National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Corporate Officer/Principal | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Gründer | - |
Ausbildung von Terry Chow
| McGill University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
National Research Council of Canada
National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Commercial Services |
